Dr. Blue is a modern hybrid strain with an undocumented lineage, as its genetic parents remain unknown. Designed for versatility, this cultivar is cultivated in both indoor and outdoor environments, offering a high-yield potential for growers. The strain requires a moderate level of technical skill to manage and reaches maturity with a standard flowering time of 63 days. Its genetic impact on the market is noted through its offspring, Blue Sugarz.

The chemical profile of Dr. Blue is defined by a primary dominance of caryophyllene, followed sequentially by myrcene, limonene, pinene, and humulene. The nuance of the strain continues with secondary and trace components including ocimene, nerolidol, linalool, beta-pinene, guaiol, p-cymene, bisabolol, eucalyptol, camphene, and caryophyllene-oxide. This diverse combination of terpenes creates a complex aromatic and flavor experience rooted in its specific chemical composition.

As a THC-dominant hybrid, Dr. Blue is known to induce effects characterized as relaxed, happy, and uplifted. These properties make the strain a functional choice for individuals seeking relief from stress and pain, while also serving as an aid for sleep. Its balance between physical sedation and mood elevation has solidified its place as a reliable tool for medicinal and recreational users alike.